Two-Drug combo shows promise in Hard-to-Treat leukemia, but trial halted early
Disease control
Terminated
This study tested a two-drug combination (ibrutinib followed by venetoclax) in 30 adults with chronic lymphocytic leukemia (CLL) that had returned or stopped responding to prior treatment. The goal was to see if the drugs could work together to clear cancer cells from the body an…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated May 17, 2026 09:04 UTC